DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,395 filers reported holding DANAHER CORPORATION in Q2 2019. The put-call ratio across all filers is 0.58 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $671,000 | +6.8% | 2,050 | -0.7% | 0.04% | +2.9% |
| Q3 2021 | $628,000 | +15.9% | 2,064 | +2.1% | 0.04% | +12.9% |
| Q2 2021 | $542,000 | +28.4% | 2,021 | +7.6% | 0.03% | +19.2% |
| Q1 2021 | $422,000 | +17.2% | 1,878 | +15.6% | 0.03% | +8.3% |
| Q4 2020 | $360,000 | +5.3% | 1,624 | +2.1% | 0.02% | -7.7% |
| Q3 2020 | $342,000 | +23.9% | 1,591 | +1.9% | 0.03% | +13.0% |
| Q2 2020 | $276,000 | +24.3% | 1,562 | -3.0% | 0.02% | +4.5% |
| Q1 2020 | $222,000 | -10.1% | 1,611 | 0.0% | 0.02% | +10.0% |
| Q4 2019 | $247,000 | +28.0% | 1,611 | +20.0% | 0.02% | +17.6% |
| Q3 2019 | $193,000 | -1.5% | 1,343 | -2.2% | 0.02% | 0.0% |
| Q2 2019 | $196,000 | -3.0% | 1,373 | -10.5% | 0.02% | -10.5% |
| Q1 2019 | $202,000 | +38.4% | 1,534 | +5.6% | 0.02% | +18.8% |
| Q4 2018 | $146,000 | -9.3% | 1,452 | -2.2% | 0.02% | -5.9% |
| Q3 2018 | $161,000 | +10.3% | 1,485 | 0.0% | 0.02% | +6.2% |
| Q2 2018 | $146,000 | +64.0% | 1,485 | +62.5% | 0.02% | +60.0% |
| Q1 2018 | $89,000 | +12.7% | 914 | +7.2% | 0.01% | +11.1% |
| Q4 2017 | $79,000 | +6.8% | 853 | 0.0% | 0.01% | +12.5% |
| Q3 2017 | $74,000 | +4.2% | 853 | 0.0% | 0.01% | -11.1% |
| Q2 2017 | $71,000 | -1.4% | 853 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $72,000 | +9.1% | 853 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $66,000 | -21.4% | 853 | -21.2% | 0.01% | -30.8% |
| Q3 2016 | $84,000 | -13.4% | 1,083 | +12.5% | 0.01% | -18.8% |
| Q2 2016 | $97,000 | +40.6% | 963 | +31.4% | 0.02% | +23.1% |
| Q1 2016 | $69,000 | +11.3% | 733 | +9.4% | 0.01% | 0.0% |
| Q4 2015 | $62,000 | +77.1% | 670 | +69.6% | 0.01% | +62.5% |
| Q3 2015 | $35,000 | +25.0% | 395 | +19.0% | 0.01% | +33.3% |
| Q2 2015 | $28,000 | +86.7% | 332 | +91.9% | 0.01% | -14.3% |
| Q1 2015 | $15,000 | +66.7% | 173 | +57.3% | 0.01% | +16.7% |
| Q4 2014 | $9,000 | -67.9% | 110 | -68.6% | 0.01% | -33.3% |
| Q3 2014 | $28,000 | 0.0% | 350 | 0.0% | 0.01% | +12.5% |
| Q2 2014 | $28,000 | +40.0% | 350 | +29.6% | 0.01% | +14.3% |
| Q1 2014 | $20,000 | +150.0% | 270 | +145.5% | 0.01% | +133.3% |
| Q4 2013 | $8,000 | – | 110 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |